Protective Effects of Pioglitazone on Cognitive Impairment and the Underlying Mechanisms: A Review of Literature

Pioglitazone, a peroxisome proliferator-activated receptor gamma (PPARγ) agonist, is known to have anti-inflammatory and anti-oxidant effects on the brain, and its clinical potential in the treatment of cognitive impairment in diseases such as Alzheimer's disease (AD) and Parkinson disease (PD)...

Descripción completa

Detalles Bibliográficos
Autores principales: Alhowail, Ahmad, Alsikhan, Rawan, Alsaud, May, Aldubayan, Maha, Rabbani, Syed Imam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9441149/
https://www.ncbi.nlm.nih.gov/pubmed/36068789
http://dx.doi.org/10.2147/DDDT.S367229

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9441149/
https://www.ncbi.nlm.nih.gov/pubmed/36068789
http://dx.doi.org/10.2147/DDDT.S367229

Ejemplares similares